Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study

被引：24
|
作者：
Moroni, Gabriella [1 ]
Gallelli, Beniamina [2 ]
Sinico, Renato Alberto [3 ,4 ]
Romano, Giulio [5 ]
Sinigaglia, Luigi [6 ]
Messa, Piergiorgio [1 ]
机构：
[1] Osped Maggiore, IRCCS Fdn Ca Granda, Div Nefrol & Dialisi, Milan, Italy
[2] Osped S Anna Como, Unita Nefrol & Dialisi, Como, Italy
[3] Azienda Osped Osped San Carlo Borromeo, Clin Immunol Unit, Milan, Italy
[4] Azienda Osped Osped San Carlo Borromeo, Renal Unit, Milan, Italy
[5] SM Misericordia Univ Hosp, Dept Nephrol, DISM, Udine, Italy
[6] Ist G Pini, Unita Operat Day Hosp, Dipartimento Reumatol, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2012年 / 71卷 / 10期
关键词：
ERYTHEMATOSUS; EFFICACY; THERAPY;
D O I：
10.1136/annrheumdis-2012-201442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1751 / 1752
页数：2
相关论文
共 50 条
  • [31] TREATMENT OF MEMBRANOUS AND DIFFUSE-PROLIFERATIVE FORMS OF LUPUS NEPHRITIS WITH INTRAVENOUS CYCLOPHOSPHAMIDE
    ZARRAGA, S
    MUNOZ, LMR
    MUNIZ, R
    AURREKOETXEA, B
    MUNOZ, RI
    MARTINEZ, JM
    GAINZA, FJ
    LAMPREABE, I
    NEFROLOGIA, 1993, 13 (06): : 538 - 544
  • [32] Pulse cyclophosphamide induction treatment in thai children with diffuse proliferative lupus nephritis
    Opastirakul, S.
    Chartapisak, W.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1614 - 1614
  • [33] Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis
    Smith, E. M. D.
    Al-Abadi, E.
    Armon, K.
    Bailey, K.
    Ciurtin, C.
    Davidson, J.
    Gardner-Medwin, J.
    Haslam, K.
    Hawley, D.
    Leahy, A.
    Leone, V.
    McErlane, F.
    Mewar, D.
    Modgil, G.
    Moots, R.
    Pilkington, C.
    Ramanan, A.
    Rangaraj, S.
    Riley, P.
    Sridhar, A.
    Wilkinson, N.
    Beresford, M. W.
    Hedrich, C. M.
    LUPUS, 2019, 28 (05) : 613 - 620
  • [34] Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial
    Grootscholten, C.
    Ligtenberg, G.
    Hagen, E. C.
    van den Wall Bake, A. W. L.
    de Glas-Vos, J. W.
    Bijl, M.
    Assmann, K. J.
    Bruijn, J. A.
    Weening, J. J.
    van Houwelingen, H. C.
    Derksen, R. H. W. M.
    Berden, J. H. M.
    KIDNEY INTERNATIONAL, 2006, 70 (04) : 732 - 742
  • [35] Pulse cyclophosphamide induction treatment in Thai children with diffuse proliferative lupus nephritis
    Opastirakul, Sauwalak
    Chartapisak, Wattana
    NEPHROLOGY, 2012, 17 (03) : 269 - 273
  • [36] Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis
    Boletis, JN
    Ioannidis, JPA
    Boki, KA
    Moutsopoulos, HM
    LANCET, 1999, 354 (9178): : 569 - 570
  • [37] Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil
    Lau, Keith K.
    Ault, Bettina H.
    Jones, Deborah P.
    Butani, Lavjay
    JOURNAL OF PEDIATRIC HEALTH CARE, 2008, 22 (05) : 282 - 288
  • [38] Mycophenolate mofetil in the treatment of lupus nephritis, in patients with failure, intolerance or relapses after treatment with steroids and cyclophosphamide
    Suria, S.
    Checa, A. D.
    NEFROLOGIA, 2007, 27 (04): : 459 - 465
  • [39] COMPARATIVE STUDY OF MYCOPHENOLATE MOFETIL (MFF) VERSUS CYCLOPHOSPHAMIDE (CYC) IN TREATMENT OF LUPUS NEPHRITIS
    Farahat, M. N. R.
    Shalaby, H.
    El-Hakeem, M.
    El-Shorbagy, M.
    Mohamed, A. G.
    El-Shahawy, M.
    INFLAMMATION RESEARCH, 2011, 60 : 234 - 234
  • [40] Cyclosporin A Versus Intravenous Cyclophosphamide in the Treatment of Lupus nephritis: The Cyclofa-Lune Study
    Pesickova, P.
    Zavada, Z.
    Rysava, R.
    Horak, H.
    Hrncir, C. .
    Rychlik, R.
    Vitova, V.
    Lukac, L.
    Dostal, D.
    Tesar, T.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (04): : 316 - 316
12345